Filing Details
- Accession Number:
- 0001237899-11-000019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-14 19:32:11
- Reporting Period:
- 2011-02-10
- Filing Date:
- 2011-02-14
- Accepted Time:
- 2011-02-14 19:32:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225474 | L Joseph Goldstein | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-10 | 5,000 | $15.80 | 5,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-10 | 2,239 | $35.27 | 2,761 | No | 4 | F | Direct | |
Common Stock | Disposition | 2011-02-11 | 2,761 | $36.66 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-02-10 | 5,000 | $0.00 | 5,000 | $15.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-01-03 | No | 4 | M | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 2,761 shares of Company stock on February 11, 2011 at prices ranging from $36.56 to $36.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 11, 2011 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.